MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakashima, S.
Right arrow Articles by Nozawa, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakashima, S.
Right arrow Articles by Nozawa, Y.

Genistein, a protein tyrosine kinase inhibitor, inhibits thromboxane A2- mediated human platelet responses

S Nakashima, T Koike and Y Nozawa

Department of Biochemistry, Gifu University School of Medicine.

An isoflavone compound, genistein, which is known as a protein tyrosine kinase inhibitor, concentration-dependently (0.1-30 micrograms/ml) suppressed human platelet aggregation, serotonin secretion, and protein tyrosine phosphorylation induced by collagen or stable thromboxane A2 analogs [U46619 and 9,11-epithio-11,12-methano-thromboxane A2 (STA2)]. However, genistein did not inhibit these thrombin (0.1 unit/ml)-induced platelet responses. Although thrombin induced an increase in the platelet phosphotyrosine content, genistein at 100 micrograms/ml only slightly attenuated thrombin-induced protein tyrosine phosphorylation. Genistein competitively inhibited [3H]U46619 binding to washed platelets, in a concentration-dependent fashion. Daidzein (another isoflavone compound), which does not have a hydroxyl group at the 5- position of genistein and lacks inhibitory activity for protein tyrosine kinase, was found to suppress [3H]U46619 binding, leading to the inhibition of collagen- or STA2-induced platelet responses. These results indicate that the blockage by genistein of platelet responses induced by collagen or thromboxane A2 is due to its preventive action on thromboxane A2 binding to the receptor, rather than via inhibition of protein tyrosine phosphorylation, and that the drug does not appear to be a particularly good inhibitor of tyrosine phosphorylation in intact platelets.

Volume 39, Issue 4, pp. 475-480, 04/01/1991
Copyright © 1991 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
Y. M. Seok, I. Baek, Y.-H. Kim, Y.-S. Jeong, I.-J. Lee, D. H. Shin, Y. H. Hwang, and I. K. Kim
Isoflavone Attenuates Vascular Contraction through Inhibition of the RhoA/Rho-Kinase Signaling Pathway
J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 991 - 998.
[Abstract] [Full Text] [PDF]


Home page
Evid Based Complement Alternat MedHome page
T. L. Johnson, M. B. Lai, J. C. K. Lai, and A. Bhushan
Inhibition of Cell Proliferation and MAP Kinase and Akt Pathways in Oral Squamous cell Carcinoma by Genistein and Biochanin A
Evid. Based Complement. Altern. Med., February 29, 2008; (2008) nen011v1.
[Abstract] [Full Text] [PDF]


Home page
Agron. J.Home page
K. A. Nelson, G. E. Rottinghaus, and T. E. Nelson
Effect of Lactofen Application Timing on Yield and Isoflavone Concentration in Soybean Seed
Agron. J., April 4, 2007; 99(3): 645 - 649.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
W.-Y. Wang, Y.-C. Wu, and C.-C. Wu
Prevention of Platelet Glycoprotein IIb/IIIa Activation by 3,4-Methylenedioxy-beta-Nitrostyrene, A Novel Tyrosine Kinase Inhibitor
Mol. Pharmacol., October 1, 2006; 70(4): 1380 - 1389.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Joy, R. C. M. Siow, D. J. Rowlands, M. Becker, A. W. Wyatt, P. I. Aaronson, C. W. Coen, I. Kallo, R. Jacob, and G. E. Mann
The Isoflavone Equol Mediates Rapid Vascular Relaxation: Ca2+-INDEPENDENT ACTIVATION OF ENDOTHELIAL NITRIC-OXIDE SYNTHASE/Hsp90 INVOLVING ERK1/2 AND Akt PHOSPHORYLATION IN HUMAN ENDOTHELIAL CELL
J. Biol. Chem., September 15, 2006; 281(37): 27335 - 27345.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
M. R. Peluso
Flavonoids Attenuate Cardiovascular Disease, Inhibit Phosphodiesterase, and Modulate Lipid Homeostasis in Adipose Tissue and Liver
Experimental Biology and Medicine, September 1, 2006; 231(8): 1287 - 1299.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. Vera, M. Galisteo, I. C. Villar, M. Sanchez, A. Zarzuelo, F. Perez-Vizcaino, and J. Duarte
Soy Isoflavones Improve Endothelial Function in Spontaneously Hypertensive Rats in an Estrogen-Independent Manner: Role of Nitric-Oxide Synthase, Superoxide, and Cyclooxygenase Metabolites
J. Pharmacol. Exp. Ther., September 1, 2005; 314(3): 1300 - 1309.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. Liu, H. Jiang, and R. W. Grange
Genistein Activates the 3',5'-Cyclic Adenosine Monophosphate Signaling Pathway in Vascular Endothelial Cells and Protects Endothelial Barrier Function
Endocrinology, March 1, 2005; 146(3): 1312 - 1320.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
D. Liu, L. L. Homan, and J. S. Dillon
Genistein Acutely Stimulates Nitric Oxide Synthesis in Vascular Endothelial Cells by a Cyclic Adenosine 5'-Monophosphate-Dependent Mechanism
Endocrinology, December 1, 2004; 145(12): 5532 - 5539.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Lung Cell. Mol. Physiol.Home page
C.-W. Lee, C.-S. Chien, and C.-M. Yang
Lipoteichoic acid-stimulated p42/p44 MAPK activation via Toll-like receptor 2 in tracheal smooth muscle cells
Am J Physiol Lung Cell Mol Physiol, May 1, 2004; 286(5): L921 - L930.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
M. G. Glazier and M. A. Bowman
A Review of the Evidence for the Use of Phytoestrogens as a Replacement for Traditional Estrogen Replacement Therapy
Arch Intern Med, May 14, 2001; 161(9): 1161 - 1172.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
E. Middleton Jr., C. Kandaswami, and T. C. Theoharides
The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer
Pharmacol. Rev., December 1, 2000; 52(4): 673 - 751.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
C.-C. Chen, Y.-T. Sun, J.-J. Chen, and K.-T. Chiu
TNF-{alpha}-Induced Cyclooxygenase-2 Expression in Human Lung Epithelial Cells: Involvement of the Phospholipase C-{gamma}2, Protein Kinase C-{alpha}, Tyrosine Kinase, NF-{kappa}B-Inducing Kinase, and I-{kappa}B Kinase 1/2 Pathway
J. Immunol., September 1, 2000; 165(5): 2719 - 2728.
[Abstract] [Full Text] [PDF]


Home page
J. Nutr.Home page
M. R. Peluso, T. A. Winters, M. F. Shanahan, and W. J. Banz
A Cooperative Interaction between Soy Protein and Its Isoflavone-Enriched Fraction Lowers Hepatic Lipids in Male Obese Zucker Rats and Reduces Blood Platelet Sensitivity in Male Sprague-Dawley Rats
J. Nutr., September 1, 2000; 130(9): 2333 - 2342.
[Abstract] [Full Text]


Home page
J Am Coll CardiolHome page
L. Wroblewski Lissin and J. P. Cooke
Phytoestrogens and cardiovascular health
J. Am. Coll. Cardiol., May 1, 2000; 35(6): 1403 - 1410.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
D. M. Tham, C. D. Gardner, and W. L. Haskell
Potential Health Benefits of Dietary Phytoestrogens: A Review of the Clinical, Epidemiological, and Mechanistic Evidence
J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2223 - 2235.
[Abstract] [Full Text]


Home page
J. Nutr.Home page
E. A. Kirk, P. Sutherland, S. A. Wang, A. Chait, and R. C. LeBoeuf
Dietary Isoflavones Reduce Plasma Cholesterol and Atherosclerosis in C57BL/6 Mice but not LDL Receptor-Deficient Mice
J. Nutr., June 1, 1998; 128(6): 954 - 959.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
I. Hers, J. Donath, G. van Willigen, and J. W. N. Akkerman
Differential Involvement of Tyrosine and Serine/Threonine Kinases in Platelet Integrin {alpha}IIbß3 Exposure
Arterioscler. Thromb. Vasc. Biol., March 1, 1998; 18(3): 404 - 414.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
M.-C. Rho, N. Nakahata, H. Nakamura, A. Murai, and Y. Ohizumi
Involvement of Phospholipase C-gamma 2 in Activation of Mitogen-Activated Protein Kinase and Phospholipase A2 by Zooxanthellatoxin-A in Rabbit Platelets
J. Pharmacol. Exp. Ther., July 1, 1997; 282(1): 496 - 504.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
J. C. Vera, A. M. Reyes, J. G. Cárcamo, F. V. Velásquez, C. I. Rivas, R. H. Zhang, P. Strobel, R. Iribarren, H. I. Scher, J. C. Slebe, et al.
Genistein Is a Natural Inhibitor of Hexose and Dehydroascorbic Acid Transport through the Glucose Transporter, GLUT1
J. Biol. Chem., April 12, 1996; 271(15): 8719 - 8724.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1991 by the American Society for Pharmacology and Experimental Therapeutics